BACKGROUND: Ectopic pregnancy is common among young women. Treatment can consist of either surgery with salpingectomy or salpingostomy or medical management with methotrexate. In addition to acute complications, treatment of ectopic pregnancy can result in longterm sequelae that include decreased fertility. Little is known about the patterns of care and predictors of treatment in women with ectopic pregnancy. Similarly, data on outcomes for various treatments are limited. OBJECTIVE: We examined the patterns of care and outcomes for women with ectopic pregnancy. Specifically, we examined predictors of medical (vs surgical) management of ectopic pregnancy and tubal conservation (salpingostomy vs salpingectomy) among women who underwent surgery. STUDY DESIGN: The Perspective database was used to identify women with a diagnosis of tubal ectopic pregnancy treated from 2006e2015. Perspective is an all-payer database that collects data on patients at hospitals from throughout the United States. Women were classified as having undergone medical treatment, if they received methotrexate, and surgical treatment, if treatment consisted of salpingostomy or salpingectomy. Multivariable models were developed to examine predictors of medical treatment and of tubal conserving salpingostomy among women who were treated surgically. RESULTS: Among the 62,588 women, 49,090 women (78.4%) were treated surgically, and 13,498 women (21.6%) received methotrexate.
T he incidence of ectopic pregnancy, defined as the implantation of a fertilized ovum outside of the endometrium, varies between 1e2% in the general population.
1,2 Despite advances in early diagnosis and management, complications that arise from ectopic pregnancy remain a significant cause of morbidity and death in the first trimester. Using pregnancy-related death estimates from 1991e1999, mortality rate was calculated to be 31.9 per 100,000 cases of ectopic pregnancy. 3 In addition to acute morbidity, ectopic pregnancy may decrease future fertility.
Women with ectopic pregnancy typically are treated either medically with methotrexate or surgically. Methotrexate is administered via intramuscular injection and offers a noninvasive route of treatment. Surgical treatment most commonly consists of either salpingectomy or salpingostomy with tubal preservation. With conservative management via methotrexate or salpingostomy, close follow up with serial measurements of quantitative beta human chorionic gonadotropin is imperative to ensure resolution. 4 Multiple clinical criteria are used to evaluate the suitability of patients for medical vs surgical treatment. 5 There are recent data that promote the benefits of tubal conservation to optimize future fertility without excessive risk of recurrent ectopic pregnancy. 6, 7 However, data are conflicting with regard to actual fertility outcomes in cases of tubal conservation, with some studies suggesting no difference in intrauterine pregnancy rates between conservative management and salpingectomy, [7] [8] [9] but others reflecting significant improvement in fertility with conservative management. 6 At minimum, the results support a thoughtful discussion with patients about the riskbenefit calculus in the context of their reproductive goals and personal preferences.
To date, little is known about the patterns of care for management of ectopic pregnancy in the United States. We performed a populationbased analysis to examine the patterns of care and outcomes for women with ectopic pregnancy. Specifically, we examined factors that are associated with medical management of ectopic pregnancy and tubal conservation among women who underwent surgery.
Methods

Patients and procedures
We used the Perspective database (Premier, Charlotte, NC) to identify women 15e60 years old with ectopic pregnancy who were treated from 2006 to the first quarter of 2015. This all-payer database captures insurance claims data from >500 acute care hospitals, which represent approximately 15% of hospitalizations nationally. 10 Hospitals included in the dataset report data on all patients who were treated within the given facility (inpatient and outpatient Demographic and clinical data included age at the time of the treatment (<20, 20-24, 25-29, 30-34, 35-39, 40-44, and 45 years), year of the treatment, marital status (married, single, and other/unknown), and primary insurance status (commercial, Medicare, Medicaid, uninsured, and unknown). Race was self-reported and categorized as white, black, Hispanic, and other/unknown. The Elixhauser comorbidity index, a measure of underlying medical comorbidity based on defined coding, was used to classify comorbid diseases in patients. The index was classified into 0, 1, and 2 based on the number of comorbid medical conditions. Hospitals were categorized based on location (urban or rural), teaching status (teaching or nonteaching), hospital bed size (<400, 400e600, and >600 beds), and region of the country defined within the dataset (Northeast, Midwest, West, and South). Annualized hospital volume was calculated for each Original Research GYNECOLOGY ajog.org 
Outcomes
The outcomes of the analysis included medical vs surgical treatment and salpingostomy vs salpingectomy among women who were treated surgically. A composite metric of any complication was analyzed among surgical patients and included hemorrhage, venous thromboembolism, shock, transfusion, renal failure, respiratory failure, bacteremia, sepsis, pneumonia, other infection, and other complications.
Statistical analysis
The demographic and clinical characteristics were compared between women with medical vs surgical treatment and between salpingostomy vs salpingectomy using c 2 and Wilcoxon rank-sum tests. Trends in treatment were compared using the Cochran-Armitage trend test. To examine predictors of medical treatment, generalized estimating equations that included all demographic and clinical characteristics that were available in the dataset were used to account for hospital-level clustering. Given that previous studies of other surgical procedures often have noted that race and insurance status are associated with treatment choice, a priori we hypothesized that these factors may also be associated with treatments for ectopic pregnancy. However, given the limited previous data that have described predictors of treatment for ectopic pregnancy, we included all of the clinical, demographic, and hospital characteristics in our multivariable models. Similar generalized estimating equations models were developed to examine predictors of salpingostomy and complications among women who underwent surgical treatment. All analyses were conducted with SAS software (version 9.4; SAS Institute, Cary, NC). All statistical tests were 2-sided. A probability value of <.05 was considered statistically significant.
Results
Among the 62,588 women who were identified with ectopic pregnancy, 49,090 women (78.4%) underwent surgery with salpingectomy or salpingostomy, and 13,498 women (21.6%) received medical treatment Figure) . Original Research GYNECOLOGY
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The overall perioperative complication rate was 23.4% (95% CI, 22.3e24.5%) after salpingostomy and 34.9% (95% CI, 34.5e35.4%) after salpingectomy (Table 3) . Hemorrhage was the most frequent complication. In a multivariable model, complications remained 31% less common after salpingostomy (aRR, 0.69; 95% CI 0.65e0.73; Table 4 ). Older women were less likely than younger women to experience a complication; Hispanic (compared with white; aRR, 1.15; 95% CI 1.07e1.24) and uninsured (compared with commercial insurance; aRR, 1.12; 95% CI 1.07e1.17) patients were more likely to experience a complication.
Comment
We noted substantial variation in the management of ectopic pregnancy in the United States. Although the rate of medical management with methotrexate is increasing, among women who undergo surgery, tubal-conserving salpingostomy is being used less frequently. There are significant race-and insurance-related disparities that are associated with treatment.
First reported in 1985, medical management of ectopic pregnancy with methotrexate works via antagonism of the folic acid pathway in DNA replication, which impairs growth of the developing trophoblast. 11, 12 The optimal regimen of systemic methotrexate is debated, although data suggest that the single-dose regimen is as effective as the multi-dose regimen and is associated with lower cost and fewer sideeffects. [13] [14] [15] Wider availability of methotrexate and use of early sonography have facilitated the growth in medical management, as also seen in other studies. 16 When surgical management is selected, the decision of salpingostomy vs salpingectomy is often based on surgeon preference, patient history, and intraoperative appearance of the tubes; however, when costeffectiveness, recurrence risk, and future fertility are factored in, neither appears clearly superior. 4, [6] [7] [8] [9] 17 Previous studies have shown that minority women are not only at increased risk for the occurrence of ectopic pregnancy but also are more likely to experience adverse outcomes.
18,19 Among Medicaid recipients in New York, California, and Illinois, the relative risk for ectopic pregnancy among black women was 1.26 compared with white women from 2000e2003. 20 Furthermore, the risk of death from ectopic pregnancy was 6.8 times higher for black women compared with white women from 2003e2007. 21 Although more severe underlying disease in underserved minorities may account for a portion of the variation in care that we noted, pathologic differences are unlikely to account for all of the variability that we noted.
There has been little previous work that has examined disparities in the medical and surgical treatment of ectopic pregnancy. 19 Using the Nationwide Inpatient Sample, Papillon-Smith et al 22 analyzed the treatment of 35,000 women with ectopic pregnancy. The investigators found that Asian/Pacific Islanders and those treated in rural hospitals were less likely to undergo nonsurgical management. This study was limited in that the data source captures only inpatient encounters. We noted that uninsured women and Medicaid recipients were less likely to receive The reasons underlying the disparities that were seen in our study group, as throughout the obstetric and gynecologic literature, are complex and myriad. Without reliable insurance coverage, women often experience delays in access to healthcare, which leads to more advanced disease at initial presentation and, thus, greater risk of morbidity and death. This may help explain the reason that uninsured women experienced more complications in our study population. Early diagnosis and treatment is particularly crucial, because a small, unruptured ectopic pregnancy affords women more choice in treatment and allows them to avoid surgery when preferred. Additional rationale for the greater incidence of salpingectomy among racial minorities may be the preponderance of gonorrhea and chlamydia infections; black women are 7 times more likely to contract chlamydia and 14 times more likely to contract gonorrhea compared with white women, which likely leads to more severe underlying tubal disease that is related to pelvic inflammatory disease. 23, 24 Finally, little is known about patient preferences and patient reported outcomes for women with ectopic pregnancy. This is clearly an area that warrants further study.
We recognize a number of important limitations. First, administrative data lack many important clinical characteristics that influence treatment selection such as hemodynamic stability, betae human chorionic gonadotropin levels, and the size of the ectopic pregnancy. A priori, the goal of our study was not to examine the effectiveness of treatment but rather to explore overall patterns of care. Second, current ICD-9 coding does not allow for the accurate distinction of laparoscopy or laparotomy. Third, we cannot exclude the possibility that treatment was misclassified in a small number of women. Likewise, although Last, as with any study of claims data, we lack data on physician and patient preferences, which includes future fertility goals, that undoubtedly influenced decision-making.
In conclusion, our study highlights inequities in healthcare delivery systems for the treatment of ectopic pregnancy. Further investigation to better understand the mechanisms underlying the disparities is needed. Ultimately, targeted interventions to reduce the morbidity that is associated with the treatment of ectopic pregnancy are needed. n
